CLINICAL_TRIALS ClinicalTrials.gov record update

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor (APTBCy)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07238712
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:57.365306+00:00
Published At: 2025-11-20T00:00:00+00:00
Record Updated At: 2025-11-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia (AML)", "Chronic Myeloid Leukemia", "Myelodysplastic Syndromes (MDS)", "Myeloprolipherative Neoplsm", "Atypical Chronic Myeloid Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-20"
protocolSection.identificationModule.nctId: "NCT07238712"
protocolSection.identificationModule.officialTitle: "Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor (APTBCy)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.